A modular approach for integrative analysis of large-scale gene-expression and drug-response data
暂无分享,去创建一个
[1] Eytan Domany,et al. Coupled Two-way Clustering Analysis of Breast Cancer and Colon Cancer Gene Expression Data , 2002, Bioinform..
[2] Alfonso Bellacosa,et al. The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. , 2003, Molecular cancer research : MCR.
[3] Robert Kiss,et al. Characterization of the activities of actin-affecting drugs on tumor cell migration. , 2006, Toxicology and applied pharmacology.
[4] J. Gutheil,et al. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein. , 1995, British Journal of Cancer.
[5] C. Verfaillie,et al. Methotrexate exacerbates tumor progression in a murine model of chronic myeloid leukemia. , 2002, The Journal of pharmacology and experimental therapeutics.
[6] H. de Thé,et al. All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. , 1991, The Journal of clinical investigation.
[7] Kiyoko F. Aoki-Kinoshita,et al. From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..
[8] Jason H. Moore,et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. , 2007, Cancer research.
[9] M. Shibuya,et al. Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes. , 1991, British Journal of Cancer.
[10] G Mathé,et al. Circadian rhythm in tolerance of mice for etoposide. , 1985, Cancer treatment reports.
[11] H. Soejima,et al. Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea. , 2005, Oncology reports.
[12] Anton J. Enright,et al. Detection of functional modules from protein interaction networks , 2003, Proteins.
[13] Jae K. Lee,et al. Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study , 2007, Molecular Cancer Therapeutics.
[14] Sven Bergmann,et al. Iterative signature algorithm for the analysis of large-scale gene expression data. , 2002, Physical review. E, Statistical, nonlinear, and soft matter physics.
[15] P. Tran,et al. Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells. , 1996, Cancer research.
[16] Roded Sharan,et al. Revealing modularity and organization in the yeast molecular network by integrated analysis of highly heterogeneous genomewide data. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] Steven J. M. Jones,et al. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] C. Mathieu,et al. In Vitro and In Vivo Analysis of the Immune System of Vitamin D Receptor Knockout Mice , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] D. Pe’er,et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data , 2003, Nature Genetics.
[20] A. Isaksson,et al. Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles , 2005, British Journal of Cancer.
[21] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.
[22] R. Clarke,et al. Human X‐Box binding protein‐1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] G. S. Johnson,et al. An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.
[24] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[25] Sergio Storari,et al. Finding biological process modifications in cancer tissues by mining gene expression correlations , 2005, BMC Bioinformatics.
[26] A. Harris,et al. Mechanisms of multidrug resistance in cancer treatment. , 1992, Acta oncologica.
[27] W. Ross,et al. DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerase II inhibition. , 1988, Molecular pharmacology.
[28] D. Henry,et al. Changing patterns of care in the management of anemia. , 1992, Seminars in oncology.
[29] C. Lok,et al. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites. , 2002, The Biochemical journal.
[30] S. Eom,et al. Caspase-mediated cleavage of p130cas in etoposide-induced apoptotic Rat-1 cells. , 2000, Molecular biology of the cell.
[31] D. Botstein,et al. Generalized singular value decomposition for comparative analysis of genome-scale expression data sets of two different organisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[32] Lothar Thiele,et al. A systematic comparison and evaluation of biclustering methods for gene expression data , 2006, Bioinform..
[33] Yaniv Ziv,et al. Revealing modular organization in the yeast transcriptional network , 2002, Nature Genetics.
[34] Rainer Breitling,et al. Network theory to understand microarray studies of complex diseases. , 2006, Current molecular medicine.
[35] Sven Bergmann,et al. Rewiring of the Yeast Transcriptional Network Through the Evolution of Motif Usage , 2005, Science.
[36] C. Allegra,et al. Enzyme studies of methotrexate-resistant human leukemic cell (K562) subclones. , 1992, Leukemia research.
[37] K. Miyazaki,et al. Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest. , 2005, International journal of oncology.
[38] P. Cuq,et al. Combined effects of GSTP1 and MRP1 in melanoma drug resistance , 2005, British Journal of Cancer.
[39] Thomas Werner,et al. Regulatory networks: Linking microarray data to systems biology , 2007, Mechanisms of Ageing and Development.
[40] S. Bergmann,et al. Similarities and Differences in Genome-Wide Expression Data of Six Organisms , 2003, PLoS biology.
[41] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[42] M. Blackburn,et al. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. , 2005, Advances in immunology.
[43] Didier Marot,et al. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. , 2007, Endocrine-related cancer.
[44] G. Church,et al. Systematic determination of genetic network architecture , 1999, Nature Genetics.
[45] M. Eisen,et al. Exploring the conditional coregulation of yeast gene expression through fuzzy k-means clustering , 2002, Genome Biology.
[46] S. Bergmann,et al. Comparative Gene Expression Analysis by a Differential Clustering Approach: Application to the Candida albicans Transcription Program , 2005, PLoS genetics.
[47] David Botstein,et al. A systematic approach to reconstructing transcription networks in Saccharomyces cerevisiae , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[48] M. Sousa,et al. Internalization of Transthyretin , 2001, The Journal of Biological Chemistry.
[49] Zhenyu Ding,et al. Predicting Cancer Drug Response by Proteomic Profiling , 2006, Clinical Cancer Research.
[50] Jiong Hu,et al. Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond. , 2007, Advances in cancer research.
[51] J. Mesirov,et al. Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[52] Neal S. Holter,et al. Fundamental patterns underlying gene expression profiles: simplicity from complexity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[53] H. Abdi. Partial Least Square Regression PLS-Regression , 2007 .
[54] M. Zweig,et al. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.
[55] Sven Bergmann,et al. Defining transcription modules using large-scale gene expression data , 2004, Bioinform..
[56] K. Hande,et al. Etoposide pharmacology. , 1992, Seminars in oncology.
[57] William C Reinhold,et al. Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel , 2006, Molecular Cancer Therapeutics.
[58] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[59] Mario Medvedovic,et al. Bayesian hierarchical model for transcriptional module discovery by jointly modeling gene expression and ChIP-chip data , 2007, BMC Bioinformatics.
[60] Feng Gao,et al. Defining transcriptional networks through integrative modeling of mRNA expression and transcription factor binding data , 2004, BMC Bioinformatics.
[61] D. Koller,et al. A module map showing conditional activity of expression modules in cancer , 2004, Nature Genetics.
[62] K. Strebhardt,et al. Rational combinations of siRNAs targeting Plk1 with breast cancer drugs , 2007, Oncogene.
[63] Y. Sugimoto,et al. Breast cancer resistance protein: Molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics , 2005, Cancer science.
[64] Jos H. Beijnen,et al. The Effect of Low pH on Breast Cancer Resistance Protein (ABCG2)-Mediated Transport of Methotrexate, 7-Hydroxymethotrexate, Methotrexate Diglutamate, Folic Acid, Mitoxantrone, Topotecan, and Resveratrol in In Vitro Drug Transport Models , 2007, Molecular Pharmacology.
[65] H Phillip Koeffler,et al. The anti-proliferative effects of 1α,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression , 2000, Oncogene.
[66] D. Kokkinakis,et al. Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma , 2005, Molecular Cancer Therapeutics.
[67] Scott H. Kaufmann,et al. Elevated DNA Polymerase α, DNA Polymerase β, and DNA Topoisomerase II in a Melphalan-resistant Rhabdomyosarcoma Xenograft That Is Cross-Resistant to Nitrosoureas and Topotecan , 1994 .
[68] Guy Perrière,et al. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis , 2003, BMC Bioinformatics.
[69] Ned S. Wingreen,et al. Finding regulatory modules through large-scale gene-expression data analysis , 2003, Bioinform..
[70] M. Loda,et al. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. , 2007, The Journal of molecular diagnostics : JMD.
[71] P. Talbot,et al. Capillary plexus development in the day five to day six chick chorioallantoic membrane is inhibited by cytochalasin D and suramin. , 2002, The Journal of experimental zoology.
[72] Daphne Koller,et al. Genome-wide discovery of transcriptional modules from DNA sequence and gene expression , 2003, ISMB.
[73] D A Scudiero,et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. , 1989, Journal of the National Cancer Institute.
[74] Y. Samuels,et al. Oncogenic mutations of PIK3CA in human cancers. , 2004, Current topics in microbiology and immunology.
[75] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[76] D. Botstein,et al. Singular value decomposition for genome-wide expression data processing and modeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.